- Adjunct Professor Terry Walsh
- Adjunct Professor
Faculty of Health,
School - Biomedical Sciences
- IHBI Membership
Institute of Health Biomedical Innovation (IHBI),
IHBI Health Projects,
IHBI Biomedical Sciences - IPTM
- Discipline *
- Biochemistry and Cell Biology, Microbiology
- View location details (QUT staff and student access only)
PhD (University of Queensland), BSc(Hons) (University of Queensland)
Metabolism, Protein analysis, Proteomics
- Comparative proteomics of cancer.
- Activities and biological targets of kallikrein proteases.
- Role of sulphur metabolism in peroxide production and elimination in lactobacilli.
- Expression and characterisation of heterologous proteins in plants.
Research program: Hormone Dependent Cancer/Infectious Diseases
Professional Experience: A/Prof Walsh has a record of research achievement that traverses the disciplines of protein and nucleic acid molecular biology, and a history of collaborative research and involvement in commercialisation. A thirty year career in protein manipulation, characterisation and identification has been highlighted by several key publications, invitations as keynote speaker and roles in international review groups. He served as chair of the Queensland Protein Group for ten years, using this position to promote the exchange of information among experts in protein biotechnology and facilitate the awareness of technological expertise and facilities that can be used by researchers locally and nationally. He has been responsible for the acquisition of major equipment, including facilities for molecular interactions, crystallography, NMR and mass spectrometers. His expertise in protein chemistry has involved him as a member of diverse research programs within the university, including those in the CTCB. He is currently involved in the CRC for Sugar Industry Innovation through Biotechnology in developing transgenic pest–resistant sugar cane, and heterologous protein expression systems. He is also a scientific advisor and technical founder of Farmacule Bioindustries, a commercial venture developing applications of plant biotechnology. A significant record in nucleic acid chemistry and manipulation includes achievements in the development of methods for the detection of mutations and for improvement of PCR technologies. He was part of the team that developed patented SNP detection technology, which was ultimately licensed internationally. His commercialisation skills are regularly used in his current position as Director of Research, monitoring and advising researchers on opportunities and mechanisms for protection of intellectual properties, and ensuring graduate students are aware of IP and commercialisation opportunities. He has been a regular contributor to IP Australia´s former annual Australian Seminar Series in various tertiary institutes.
For publications by this staff member, visit QUT ePrints, the University's research repository.